BMT CTN Protocol 1501: A randomized, Phase II Multicenter, Open Label Study Evaluating Sirolimus and Prednisone in Patients with Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus Host Disease
|Effective start/end date||11/8/16 → 8/31/19|
- National Marrow Donor Program
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.